Semin Reprod Med 2012; 30(04): 289-301
DOI: 10.1055/s-0032-1313908
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Aneuploidy Screening for Embryo Selection

Elpida Fragouli
1   Reprogenetics UK
,
Dagan Wells
1   Reprogenetics UK
2   Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2012 (online)

Abstract

Chromosome abnormalities are extremely common in human oocytes and embryos and are associated with a variety of negative outcomes for both natural cycles and those using assisted conception techniques. Embryos containing the wrong number of chromosomes (aneuploidy) may fail to implant in the uterus, miscarry, or lead to children with serious medical problems (e.g., Down syndrome). Preimplantation genetic screening (PGS) is a method that seeks to improve the outcomes of assisted reproductive treatments, such as in vitro fertilization (IVF), by ensuring that the embryos chosen for transfer to the uterus are chromosomally normal. Here we summarize published and novel data concerning the frequency and variety of chromosomal abnormalities seen in oocytes and embryos at the cleavage and blastocyst stages of development. Clinical outcomes of studies using PGS are presented, and the controversy over the use of chromosome screening as a tool for embryo selection is discussed. We describe validation and preliminary clinical data from the new generation of methods being used for PGS, including comparative genomic hybridization (CGH), microarrays (aCGH and single nucleotide polymorphism arrays), and quantitative polymerase chain reaction. These methodologies allow comprehensive chromosomal analysis, provide high accuracy, and have yielded encouraging preliminary clinical data. The combination of advances in genetics and embryology seems poised to usher in a new era in the treatment of infertility.

 
  • References

  • 1 Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990; 344 (6268) 768-770
  • 2 Harper JC, Harton G. The use of arrays in preimplantation genetic diagnosis and screening. Fertil Steril 2010; 94 (4) 1173-1177
  • 3 Goossens V, Harton G, Moutou C, Traeger-Synodinos J, Van Rij M, Harper JC. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod 2009; 24 (8) 1786-1810
  • 4 Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril 2010; 94 (5) 1700-1706
  • 5 Alfarawati S, Fragouli E, Colls P, Wells D. First births after preimplantation genetic diagnosis of structural chromosome abnormalities using comparative genomic hybridization and microarray analysis. Hum Reprod 2011; 26 (6) 1560-1574
  • 6 Treff NR, Northrop LE, Kasabwala K, Su J , et al. Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil Steril 2011; 95: 1606-1612.e2
  • 7 Delhanty JD, Harper JC, Ao A, Handyside AH, Winston RM. Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet 1997; 99 (6) 755-760
  • 8 Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000; 6 (11) 1055-1062
  • 9 Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 1993; 8 (12) 2185-2191
  • 10 Kuliev A, Cieslak J, Verlinsky Y. Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet Genome Res 2005; 111 (3–4) 193-198
  • 11 Mantzouratou A, Mania A, Fragouli E , et al. Variable aneuploidy mechanisms in embryos from couples with poor reproductive histories undergoing preimplantation genetic screening. Hum Reprod 2007; 22 (7) 1844-1853
  • 12 Fragouli E, Katz-Jaffe M, Alfarawati S , et al. Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure. Fertil Steril 2010; 94 (3) 875-887
  • 13 Colls P, Escudero T, Cekleniak N, Sadowy S, Cohen J, Munné S. Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue.”. Fertil Steril 2007; 88 (1) 53-61
  • 14 Munné S, Fragouli E, Colls P, Katz-Jaffe M, Schoolcraft W, Wells D. Improved detection of aneuploid blastocysts using a new 12-chromosome FISH test. Reprod Biomed Online 2010; 20 (1) 92-97
  • 15 Fragouli E, Alfarawati S, Daphnis DD , et al. Cytogenetic analysis of human blastocysts with the use of FISH, CGH and aCGH: scientific data and technical evaluation. Hum Reprod 2011; 26 (2) 480-490
  • 16 Fragouli E, Alfarawati S, Goodall NN, Sánchez-García JF, Colls P, Wells D. The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidy. Mol Hum Reprod 2011; ; April 15 (Epub ahead of print)
  • 17 Gutiérrez-Mateo C, Colls P, Sánchez-García J , et al. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011; 95 (3) 953-958
  • 18 Handyside AH, Harton GL, Mariani B , et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 2010; 47 (10) 651-658
  • 19 Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod 2010; 16 (8) 583-589
  • 20 Munné S, Sandalinas M, Escudero T, Márquez C, Cohen J. Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect. Reprod Biomed Online 2002; 4 (3) 223-232
  • 21 Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet 2000; 106 (2) 210-217
  • 22 Simpson JL, Bombard AT. Chromosomal abnormalities in spontaneous abortion: frequency, pathology and genetic counselling. In: Edmonds K, Bennett MJ, eds. Spontaneous Abortion. London, UK: Blackwell; 1987: 51
  • 23 Donoso P, Staessen C, Fauser BCJM, Devroey P. Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update 2007; 13 (1) 15-25
  • 24 Gianaroli L, Magli MC, Ferraretti AP, Munné S. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril 1999; 72 (5) 837-844
  • 25 Munné S, Magli C, Cohen J , et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 1999; 14 (9) 2191-2199
  • 26 Munné S, Sandalinas M, Escudero T , et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online 2003; 7 (1) 91-97
  • 27 Munné S, Chen S, Fischer J , et al. Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril 2005; 84 (2) 331-335
  • 28 Munné S, Fischer J, Warner A, Chen S, Zouves C, Cohen J. Referring Centers PGD Group. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study. Fertil Steril 2006; 85 (2) 326-332
  • 29 Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril 2005; 84 (2) 319-324
  • 30 Staessen C, Platteau P, Van Assche E , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004; 19 (12) 2849-2858
  • 31 Munné S, Gianaroli L, Tur-Kaspa I , et al. Substandard application of preimplantation genetic screening may interfere with its clinical success. Fertil Steril 2007; 88 (4) 781-784
  • 32 Cohen J, Wells D, Munné S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 2007; 87 (3) 496-503
  • 33 De Vos A, Staessen C, De Rycke M , et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod 2009; 24 (12) 2988-2996
  • 34 Mastenbroek S, Twisk M, Van Echten-Arends J , et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007; 357: 9-17
  • 35 Braude P, Flinter F. Use and misuse of preimplantation genetic testing. BMJ 2007; 335 (7623) 752-754
  • 36 Cohen J, Grifo JA. Multicentre trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings. Reprod Biomed Online 2007; 15 (4) 365-366
  • 37 Kuliev A, Verlinsky Y. Impact of preimplantation genetic diagnosis for chromosomal disorders on reproductive outcome. RBM Online 2008; 16: 9-10
  • 38 Ethics Committee of the American Society for Reproductive Medicine. Sharedrisk or refund programs in assisted reproduction. Fertil Steril 2004; 82 (Suppl. 01) S249-S250
  • 39 Blockeel C, Schutyser V, De Vos A , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online 2008; 17 (6) 848-854
  • 40 Hardarson T, Hanson C, Lundin K , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 2008; 23 (12) 2806-2812
  • 41 Mersereau JE, Pergament E, Zhang X, Milad MP. Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertil Steril 2008; 90 (4) 1287-1289
  • 42 Staessen C, Verpoest W, Donoso P , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod 2008; 23 (12) 2818-2825
  • 43 Meyer LR, Klipstein S, Hazlett WD, Nasta T, Mangan P, Karande VC. A prospective randomized controlled trial of preimplantation genetic screening in the “good prognosis” patient. Fertil Steril 2009; 91 (5) 1731-1738
  • 44 Schoolcraft WB, Katz-Jaffe MG, Stevens J, Rawlins M, Munné S. Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril 2009; 92 (1) 157-162
  • 45 Debrock S, Melotte C, Spiessens C , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril 2010; 93 (2) 364-373
  • 46 Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC. European Society for Human Reproduction and Embryology (ESHRE) PGD Consortium/Embryology Special Interest Group. ESHRE PGD Consortium/Embryology Special Interest Group—best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 2011; 26 (1) 41-46
  • 47 Wells D, Sherlock JK, Handyside AH, Delhanty JD. Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. Nucleic Acids Res 1999; 27 (4) 1214-1218
  • 48 Kallioniemi A, Kallioniemi OP, Sudar D , et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258 (5083) 818-821
  • 49 Wilton L, Williamson R, McBain J, Edgar D, Voullaire L. Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. N Engl J Med 2001; 345 (21) 1537-1541
  • 50 Gutiérrez-Mateo C, Benet J, Wells D , et al. Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis. Hum Reprod 2004; 19 (12) 2859-2868
  • 51 Fragouli E, Wells D, Thornhill A , et al. Comparative genomic hybridization analysis of human oocytes and polar bodies. Hum Reprod 2006; 21 (9) 2319-2328
  • 52 Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod 2008; 23 (11) 2596-2608
  • 53 Voullaire L, Wilton L, McBain J, Callaghan T, Williamson R. Chromosome abnormalities identified by comparative genomic hybridization in embryos from women with repeated implantation failure. Mol Hum Reprod 2002; 8 (11) 1035-1041
  • 54 Voullaire L, Collins V, Callaghan T, McBain J, Williamson R, Wilton L. High incidence of complex chromosome abnormality in cleavage embryos from patients with repeated implantation failure. Fertil Steril 2007; 87 (5) 1053-1058
  • 55 Hill DL. Aneuploidy screening of preimplantation embryos using comparative genomic hybridization versus fluorescence in situ hybridization techniques. Fertil Steril 2003; 80 (4) 873-874 ; discussion 875
  • 56 Munné S, Wells D. Questions concerning the suitability of comparative genomic hybridization for preimplantation genetic diagnosis. Fertil Steril 2003; 80 (4) 871-872 , discussion 875
  • 57 Verlinsky Y, Kuliev A. Preimplantation diagnosis for aneuploidies using fluorescence in situ hybridization or comparative genomic hybridization. Fertil Steril 2003; 80 (4) 869-870 ; discussion 875
  • 58 Gutiérrez-Mateo C, Colls P, Sánchez-García J , et al. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011; 95 (3) 953-958
  • 59 Magli MC, Sandalinas M, Escudero T , et al. Double locus analysis of chromosome 21 for preimplantation genetic diagnosis of aneuploidy. Prenat Diagn 2001; 21 (12) 1080-1085
  • 60 Treff NR, Su J, Tao X, Levy B, Scott Jr RT. Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril 2010; 94 (6) 2017-2021
  • 61 Hassold T, Hall H, Hunt P. The origin of human aneuploidy: where we have been, where we are going. Hum Mol Genet 2007; 16 Spec No. 2: R203-R208
  • 62 Zenzes MT, Casper RF. Cytogenetics of human oocytes, zygotes, and embryos after in vitro fertilization. Hum Genet 1992; 88 (4) 367-375
  • 63 Angell RR. Predivision in human oocytes at meiosis I: a mechanism for trisomy formation in man. Hum Genet 1991; 86 (4) 383-387
  • 64 Sandalinas M, Márquez C, Munné S. Spectral karyotyping of fresh, non-inseminated oocytes. Mol Hum Reprod 2002; 8 (6) 580-585
  • 65 Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod Biomed Online 2003; 6 (1) 54-59
  • 66 Pellestor F, Andréo B, Arnal F, Humeau C, Demaille J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet 2003; 112 (2) 195-203
  • 67 Fragouli E, Escalona A, Gutiérrez-Mateo C , et al. Comparative genomic hybridization of oocytes and first polar bodies from young donors. Reprod Biomed Online 2009; 19 (2) 228-237
  • 68 Kuliev A, Verlinsky Y. Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update 2004; 10 (5) 401-407
  • 69 Kuliev A, Zlatopolsky Z, Kirillova I, Spivakova J, Cieslak Janzen J. Meiosis errors in over 20,000 oocytes studied in the practice of preimplantation aneuploidy testing. Reprod Biomed Online 2011; 22 (1) 2-8
  • 70 Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty JD, Munné S. First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril 2002; 78 (3) 543-549
  • 71 Obradors A, Fernandez E, Oliver-Bonet M, Rius M , et al. Birth of a healthy boy after a double factor PGD in a couple carrying a genetic disease and at risk for aneuploidy: case report. Hum Reprod 2008; 23: 1949-1956
  • 72 Fishel S, Gordon A, Lynch C, Dowell K , et al. Live birth after polar body array comparative genomic hybridization prediction of embryo ploidy—the future of IVF? . Fertil Steril 2010; 93: 1006.e7-1006.e10
  • 73 Treff NR, Su J, Kasabwala N, Tao X, Miller KA, Scott Jr RT. Robust embryo identification using first polar body single nucleotide polymorphism microarray-based DNA fingerprinting. Fertil Steril 2010; 93 (7) 2453-2455
  • 74 Geraedts J, Collins J, Gianaroli L , et al. What next for preimplantation genetic screening? A polar body approach!. Hum Reprod 2010; 25 (3) 575-577
  • 75 Schoolcraft WB, Gardner DK, Lane M, Schlenker T, Hamilton F, Meldrum DR. Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999; 72 (4) 604-609
  • 76 McArthur SJ, Leigh D, Marshall JT, de Boer KA, Jansen RP. Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil Steril 2005; 84 (6) 1628-1636
  • 77 Evsikov S, Verlinsky Y. Mosaicism in the inner cell mass of human blastocysts. Hum Reprod 1998; 13 (11) 3151-3155
  • 78 Magli MC, Jones GM, Gras L, Gianaroli L, Korman I, Trounson AO. Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. Hum Reprod 2000; 15 (8) 1781-1786
  • 79 Sandalinas M, Sadowy S, Alikani M, Calderon G, Cohen J, Munné S. Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage. Hum Reprod 2001; 16 (9) 1954-1958
  • 80 Bielanska M, Tan SL, Ao A. High rate of mixoploidy among human blastocysts cultured in vitro. Fertil Steril 2002; 78 (6) 1248-1253
  • 81 Santos MA, Teklenburg G, Macklon NS , et al. The fate of the mosaic embryo: chromosomal constitution and development of day 4, 5 and 8 human embryos. Hum Reprod 2010; 25 (8) 1916-1926
  • 82 Coonen E, Derhaag JG, Dumoulin JC , et al. Anaphase lagging mainly explains chromosomal mosaicism in human preimplantation embryos. Hum Reprod 2004; 19 (2) 316-324
  • 83 Jansen RPS, Bowman MC, de Boer KA, Leigh DA, Lieberman DB, McArthur SJ. What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod 2008; 23 (7) 1476-1478
  • 84 Northrop LE, Treff NR, Levy B, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod 2010; 16 (8) 590-600
  • 85 Johnson DS, Cinnioglu C, Ross R , et al. Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass. Mol Hum Reprod 2010; 16 (12) 944-949
  • 86 Scott R, Tao X, Taylor D, Ferry KM, Treff NR. A prospective randomized controlled trial demonstrating significantly increased clinical pregnancy rates following 24 chromosome aneuploidy screening: biopsy and analysis on day 5 with fresh transfer. Fertil Steril 2010; 94: S2